A nasal Covid-19 vaccine will be easy to give to school-going children who bear a “very mild” load of the disease but they are infectious too, AIIMS Director Randeep Guleria said on Wednesday.
The noted pulmonologist, who was interacting with the personnel of the National Disaster Response Force (NDRF) during their 16th Raising Day celebrations in New Delhi, also said that people who have contracted coronavirus should also get the jab about 4-6 weeks after recovery.
16th Raising Day Celebration
Academic Session:-
Infectious Diseases: Emergencies and Challenges Ahead
by
Dr Randeep Guleria, Director AIIMS#Committed2Serve#NDRF4U#16thRaisingDay @satyaprad1 @PIBHomeAffairs @ndmaindia @HMOIndia pic.twitter.com/sqo1iure8s— NDRF 🇮🇳 (@NDRFHQ) January 20, 2021
“It (coronavirus infection) is very mild in children but they are infectious. They can spread the disease.”
“The vaccines that have come are not approved for children because there have been no studies conducted on children but this (vaccination) is a very important step and trials are being done,” he said.
The chief of the premier Delhi-based All India Institute of Medical Sciences (AIIMS) said, “Once children start going to the school regularly and they contract the Covid-19 infection, they will not have much problem but if they bring it home they can spread it to their parents or grandparents.”
“Vaccines for children may come later…Bharat Biotech is trying to get approved a nasal vaccine. Such a vaccine will be very easy to be given to children as it is a spray and not a jab and hence compliance is more.”
“In half-an-hour, you can vaccinate an entire class. So, if that (nasal vaccine) is approved it will be even easier to give the vaccine (for Covid-19),” Guleria said in reply to a question.
He was also asked by the NDRF personnel if a person who has recovered from Covid-19 should get vaccinated with India commissioning two vaccines last week.
“A vaccine jab is essential for them (recovered from coronavirus) due to two reasons.”
“One is you are not sure how strong is your post-Covid-19 immunity and it has been seen quite a few times that those who had a mild to moderate infection their anti-body response has been less and we also don’t know how long will it be,” he said.
A vaccine will be “beneficial” for such an individual as it will act as a “booster” and if anti-bodies are depleting, with the vaccine it will be back to a high level, he said.
“So, you should get the vaccine if you have been infected with Covid-19 but if it has happened recently say like 7-10 days then one should wait and take the jab after maybe 4-6 weeks,” he said.
Before replying to queries, Guleria also gave a PowerPoint presentation on the topic “Infectious Diseases: Emergencies and Challenges Ahead” and said “bio-terrorism” is an upcoming challenge.
He said densely populated countries like India “provide an opportunity” for the outbreak of infectious disease emergencies as it is coupled with the phenomenon of crowding and urbanisation.
He batted for having a “very good surveillance system” to better combat coronavirus like diseases and epidemics.
He said the country did “aggressive” work with a strong political will in the aftermath of the Covid-19 outbreak and said the need of the hour was to have lab-based surveillance and more and more trained public health officials.
“We need to enhance our research capacity and we should not forget what we learnt during coronavirus outbreak,” Guleria said.